Acute insulin resistance assessed by the homeostatic model assessment in acute coronary syndromes without previously known diabetes

Angiology

Volumn 65, Issue 6, 2014, Pages 519-524

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Attanà, Paola ^a   Mattesini, Alessio ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

acute coronary syndrome; acute insulin resistance; early death; without previously known diabetes

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; EPIDEMIOLOGY; HEART STROKE VOLUME; INTENSIVE CARE UNIT; ITALY; LEUKOCYTE COUNT; MORTALITY; PROGNOSIS; STATISTICAL MODEL; VERY ELDERLY;

TROPONIN I;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BODY MASS INDEX; FEMALE; HOMEOSTASIS; HOSPITAL MORTALITY; HUMANS; INSULIN RESISTANCE; INTENSIVE CARE UNITS; ITALY; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME; TROPONIN I;

EID: 84899488284     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713489018     Document Type: Article

References (28)

1. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction. Diab Vasc Dis Res. 2011 ; 8 (1). 35-42
2. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response. Diab Vasc Dis Res. 2010 ; 7 (2). 131-137
3. Lazzeri C, Valente S, Chiostri M, Attanà P, Picariello C, Gensini GF. The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia [published online October 9, 2011]. Acta Diabetol. 2011 ;:
4. Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol. 2009 ; 26 (10). 856-862
5. Van de Werf F, Ardissino D, Bueno H, et al. Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines. Expert Rev Cardiovasc Ther. 2012 ; 10 (4). 489-503
6. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000 ; 36 (3). 959-969
7. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008 ; 29 (23). 2909-2945
8. Wijns W, Kolh P, Danchin N, et al. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Association for Percutaneous Cardiovascular Interventions. Guidelines on myocardial revascularization. Eur Heart J. 2010 ; 31 (20). 2501-2555
9. Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med (Hagerstown). 2010 ; 11 (1). 7-13
10. Valente S, Lazzeri C, Saletti E, Chiostri M, Gensini GF. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence. J Cardiovasc Med (Hagerstown). 2008 ; 9 (11). 1083-1087
11. Boden WE, O'Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007 ; 356 (15). 1503-1516
12. Lazzeri C, Valente S, Chiostri M, Picariello C, Attanà P, Gensini GF. The prognostic impact of glycated hemoglobin in diabetic ST-elevation myocardial infarction. Int J Cardiol. 2011 ; 151 (2). 250-252
13. Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol. 2010 ; 138 (2). 206-209
14. Valente S, Lazzeri C, Chiostri M, et al. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol. 2009 ; 132 (1). 84-89
15. Balkau B, Charles M.. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999 ; 16 (5). 442-443
16. Panza-Nduli J, Coulic V, Willems D, et al. Influence of blood insulin measurement in acute coronary syndrome. Crit Pathw Cardiol. 2011 ; 10 (4). 185-188
17. Caccamo G, Bonura F, Vitale G, et al. Insulin resistance and acute coronary syndrome. Atherosclerosis. 2010 ; 211 (2). 672-675
18. Garcia RG, Rincon MY, Arenas WD, et al. Hyperinsulinemia is a predictor of new cardiovascular events in Colombina patients with a first myocardial infarction. Int J Cardiol. 2011 ; 148 (1). 85-90
19. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995 ; 26 (1). 57-65
20. Malmberg K.. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997 ; 314 (7093). 1512-1515
21. van der Horst IC, Zijlstra F, van't Hof AW, et al. Glucoseinsulin- potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the Glucose-Insulin-Potassium Study: a randomized trial. J Am Coll Cardiol. 2003 ; 42 (5). 784-791
22. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin- potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999 ; 13 (3). 191-200
23. Kosiborod M, Mc Guire DK. Glucose-lowering targets for patients with cardiovascular disease focus on inpatient management of patients with acute coronary syndromes. Circulation. 2010 ; 122 (25). 2736-2744
24. Young LH, renfu Y, Russel R, et al. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 1997 ; 95 (2). 415-422
25. Iliadis F, adoglou N, Didangelos T. Insulin and heart. Diabetes Res Clin Pract. 2011 ; 93 (suppl 1). S86 - S91
26. Shipp JC, Opie LH, Challoner D. Fatty acid and glucose metabolism in the perfused heart. Nature. 1961 ; 189: 1018-1019
27. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994 ; 343 (8890). 155-158
28. Oliver MF. Control of free fatty acids during acute myocardial ischaemia. Heart. 2010 ; 96 (23). 1883-1884